1-6 of 6
immune tolerance
Close
Sort by
Journal Articles

What is the role of an extended half-life product in immune tolerance induction in a patient with severe hemophilia A and high-titer inhibitors?

Maissaa Janbain, Steven Pipe
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2016) 2016 (1): 648–649.
https://doi.org/10.1182/asheducation-2016.1.648
Published: 2016
Journal Articles

Toward optimal therapy for inhibitors in hemophilia

Christine L. Kempton, Shannon L. Meeks
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2014) 2014 (1): 364–371.
https://doi.org/10.1182/asheducation-2014.1.364
Published: 2014
Journal Articles

What is the Evidence for the Use of Immunomodulatory Agents to Eradicate Inhibitory Antibodies in Patients with Severe Hemophilia A Who Have Previously Failed to Respond to Immune Tolerance Induction?

Michael U. Callaghan, Patrick F. Fogarty
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2011) 2011 (1): 405–406.
https://doi.org/10.1182/asheducation-2011.1.405
Published: 2011
Journal Articles

The Role of Immunomodulation in the Management of Factor VIII Inhibitors

David Lillicrap
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2006) 2006 (1): 421–425.
https://doi.org/10.1182/asheducation-2006.1.421
Published: 2006
Journal Articles

New Perspectives in Hemophilia Treatment

Craig M. Kessler
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2005) 2005 (1): 429–435.
https://doi.org/10.1182/asheducation-2005.1.429
Published: 2005
Journal Articles

Congenital Bleeding Disorders

Margaret E. Rick, Christopher E. Walsh, Nigel S. Key
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2003) 2003 (1): 559–574.
https://doi.org/10.1182/asheducation-2003.1.559
Published: 2003